Risk, Incidence, and Mortality of Breast Cancer in Primary Sjogren's Syndrome: A Systematic Review and Meta-Analysis

被引:8
|
作者
Deng, Jian [1 ,2 ]
Liu, Mengsi [3 ]
Xiao, Ruoyi [3 ]
Wang, Jin [3 ]
Liao, Xibei [3 ]
Ye, Zhen [3 ]
Sun, Zhen [3 ]
机构
[1] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Thyroid Breast Surg, Hengyang, Peoples R China
[2] Univ South China, Affiliated Hosp 2, Ctr Breast Canc Prevent & Treatment, Hengyang Med Sch, Hengyang, Peoples R China
[3] Univ South China, Hengyang Med Sch, Dept Clin Med, Hengyang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
primary Sjogren's syndrome (pSS); breast cancer; risk factor; protective factor; mortality; incidence; meta-analysis; MALIGNANCY RISK; COHORT; ASSOCIATION; DISEASES; LYMPHOMA;
D O I
10.3389/fimmu.2022.904682
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Primary Sjogren's syndrome (pSS) and breast cancer are a highly prevalent autoimmune disease and malignancy, respectively, both occurring predominantly in females. Whether there is a link between these two diseases is uncertain. We conducted a systematic review and meta-analysis to investigate the risk, incidence, and mortality of breast cancer in patients with pSS. Methods: We systematically searched Embase, PubMed, and Web of Science on January 31, 2022 to identify the study that assessed risk, incidence, or mortality of breast cancer in pSS. The fixed or random-effects models were applied to pool the effect estimates based on heterogeneity measured by Cochran's Q-test and Higgins' I-2. Results: Ten studies involving 725,805 participants and 64,836 pSS patients were included in our analysis. The pooled result showed that, overall, pSS was not associated with the risk (SIR=0.92, 95%CI: 0.66-1.29, P=0.646) and mortality (HR = 0.78, 95%CI: 0.26-2.34, P = 0.664) of breast cancer; however, when stratified by geographic region, we found that patients with pSS in Asian countries (SIR=1.32, 95%CI: 1.10-1.58, P=0.003) and Argentina (SIR=3.76, 95%CI: 1.04-9.45, P=0.019) had an elevated risk of breast cancer, while pSS in Europe was associated with a reduced risk (SIR=0.61, 95%CI: 0.51-0.73, P < 0.001). The pooled result from 28,635 female pSS patients indicated that the incidence of breast cancer was 2.15 (95% CI: 1.33-3.50) per 1000 person/years. Conclusion: This study suggests that there may be geographical differences in the association between pSS and breast cancer risk; patients with pSS in European countries are associated with a lower risk of breast cancer, while Asia and Argentina are the opposite. Future research is needed to further characterize the effect of pSS on breast cancer risk and the pathophysiological mechanisms underlying this association to unravel the complex relationship between the two.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance
    Catherine Meads
    Ikhlaaq Ahmed
    Richard D. Riley
    Breast Cancer Research and Treatment, 2012, 132 : 365 - 377
  • [32] A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance
    Meads, Catherine
    Ahmed, Ikhlaaq
    Riley, Richard D.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 365 - 377
  • [33] Hyperuricemia And The Risk Of Stroke Incidence And Mortality: A Systematic Review And Meta-analysis
    Jiang, Haiyan
    CEREBROVASCULAR DISEASES, 2023, 52 : 203 - 203
  • [34] The Association of Obstructive Sleep Apnea With Breast Cancer Incidence and Mortality: A Systematic Review and Meta-analysis
    Yap, Dominic Wei Ting
    Tan, Nicole Kye Wen
    Tan, Benjamin Kye Jyn
    Teo, Yao Hao
    Tan, Veronique Kiak Mien
    See, Anna
    Toh, Song Tar
    JOURNAL OF BREAST CANCER, 2022, 25 (03) : 149 - 163
  • [35] Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis
    Lundqvist, Adam
    Andersson, Emelie
    Ahlberg, Ida
    Nilbert, Mef
    Gerdtham, Ulf
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 (05): : 804 - 813
  • [36] Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: Systematic review and meta-analysis
    Bardia, Aditya
    Tleyjeh, Imad M.
    Cerhan, James R.
    Sood, Amit K.
    Limburg, Paul J.
    Erwin, Patricia J.
    Montori, Victor M.
    MAYO CLINIC PROCEEDINGS, 2008, 83 (01) : 23 - 34
  • [37] Mortality in Cushing's syndrome: A systematic review and meta-analysis
    Graversen, D.
    Vestergaard, P.
    Stochholm, K.
    Gravholt, C. H.
    Jorgensen, J. O. L.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) : 278 - 282
  • [38] Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis
    Tejera-Vaquerizo, A.
    Descalzo-Gallego, M. A.
    Otero-Rivas, M. M.
    Posada-Garcia, C.
    Rodriguez-Pazos, L.
    Pastushenko, I.
    Marcos-Gragera, R.
    Garcia-Doval, I.
    ACTAS DERMO-SIFILIOGRAFICAS, 2016, 107 (04): : 318 - 328
  • [39] Association between Primary Sjogren's Syndrome, Cardiovascular and Cerebrovascular Events: A Systematic Review and Meta-Analysis
    Yong, Wai Chung
    Sanguankeo, Anawin
    Upala, Sikarin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] Rituximab Effectiveness and Safety for Treating Primary Sjogren's Syndrome (pSS): Systematic Review and Meta-Analysis
    do Valle Souza, Francine Bertolais
    Martiniano Porfirio, Gustavo Jose
    Gomes Andriolo, Brenda Nazare
    de Albuquerque, Julia Vajda
    Moca Trevisani, Virginia Fernandes
    PLOS ONE, 2016, 11 (03):